Table 1.
Characteristics of 8,392 therapy-naive HIV-infected individuals when CD4 first falls between 500 and 200*, HIV-CAUSAL Collaboration
| Characteristic | No. of individuals (%) | |
|---|---|---|
| Sex | Male | 6, 500 (77.5) |
| Female | 1, 892 (22.6) | |
| Age, years | < 35 | 3, 391 (40.4) |
| 35 – 50 | 4,242 (50.6) | |
| > 50 | 759 (9.0) | |
| Transmission group | Heterosexual | 2, 457 (29.3) |
| Homosexual | 4, 122 (49.1) | |
| Injection drug use | 779 (9.3) | |
| Other/Unknown** | 1, 034 (12.3) | |
| CD4 cell count, per mm3 | 200 – 349 | 914 (10.9) |
| 350 – 499 | 7, 478 (89.1) | |
| HIV RNA, copies/mL | < 10,000 | 2, 767 (33.0) |
| 10,000 – 100,000 | 4, 255 (50.7) | |
| > 100,000 | 1, 370 (16.3) | |
| Calendar year | 1996 – 1998 | 1, 299 (15.5) |
| 1999 – 2000 | 1, 191 (14.2) | |
| 2001 – 2003 | 2, 298 (27.4) | |
| ≥ 2004 | 3, 604 (43.0) | |
| Cohort | UK CHIC | 1, 785 (21.3) |
| ATHENA | 650 (7.8) | |
| FHDH-ANRS CO4 | 3, 390 (40.4) | |
| SHCS | 523 (6.2) | |
| PISCIS | 343 (4.1) | |
| CoRIS | 451 (5.4) | |
| Seroconverters | 641 (7.6) | |
| VACS-VC | 609 (7.3) |
*
Table is identical to last two columns of Table 1 in Cain et al (2011)
**
Other/Unknown included all VACS-VC participants.